[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d14022e1fcd73e16bcf89b68af7ff0927d3baf5a73ccef9f60e174f1f433f7bb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733762460,
      "headline": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
      "id": 131936010,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d14022e1fcd73e16bcf89b68af7ff0927d3baf5a73ccef9f60e174f1f433f7bb"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Retain Insulet Stock in Your Portfolio Now?",
    "summary": "PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.",
    "url": "https://finnhub.io/api/news?id=a55073e277db6ebccf548b237fcc88057ccc6d5cbcdaae8618ece6f7db33d4c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733746920,
      "headline": "Should You Continue to Retain Insulet Stock in Your Portfolio Now?",
      "id": 131870422,
      "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.",
      "url": "https://finnhub.io/api/news?id=a55073e277db6ebccf548b237fcc88057ccc6d5cbcdaae8618ece6f7db33d4c2"
    }
  }
]